This is the bit on their marketing that Derek Lowe highlighted from the FDA letter:<p>For example, your company’s website at www.23andme.com/health (most recently viewed on November 6, 2013) markets the PGS for providing “health reports on 254 diseases and conditions,” including categories such as “carrier status,” “health risks,” and “drug response,” and specifically as a “first step in prevention” that enables users to “take steps toward mitigating serious diseases” such as diabetes, coronary heart disease, and breast cancer.<p><a href="http://pipeline.corante.com/archives/2013/11/27/23_and_me_and_the_fda.php" rel="nofollow">http://pipeline.corante.com/archives/2013/11/27/23_and_me_an...</a>